Investigating placebo effects in irritable bowel syndrome: A novel research design

被引:22
作者
Conboy, LA
Wasserman, RH
Jacobson, EE
Davis, RB
Legedza, ATR
Park, M
Rivers, AL
Morey, EB
Nam, BH
Lasagna, L
Kirsch, I
Lembo, AJ
Kaptchuk, TJ
Kerr, CE
机构
[1] Harvard Univ, Sch Med, Osher Inst, Div Res & Educ Complementary & Integrat Therapies, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA
[4] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA
[5] Univ Plymouth, Sch Appl Psychosocial Studies, Plymouth PL4 8AA, Devon, England
[6] Beth Israel Deaconess Med Ctr, Dept Gastroenterol, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
placebo effect; randomized clinical trial; research methodology; irritable bowel syndrome; placebo run-in; patient-practitioner relationship; qualitative methods;
D O I
10.1016/j.cct.2005.11.012
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Little is known about placebo effects with scientific precision. Poor methodology has confounded our understanding of the magnitude and even the existence of the placebo effect. Investigating placebo effects presents special research challenges including: the design of appropriate controls for studying placebo effects including separating such effects from natural history and regression to the mean, the need for large sample sizes to capture expected small effects, and the need to understand such potential effects from a patient's perspective. This article summarizes the methodology of an ongoing NIH-funded randomized controlled trial aimed at investigating whether the placebo effect in irritable bowel syndrome (IBS) exists and whether the magnitude of such an effect can be manipulated to vary in a manner analogous to '' dose dependence.'' The trial also uses an innovative combination of quantitative and qualitative methods. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:123 / 134
页数:12
相关论文
共 78 条
[1]  
[Anonymous], 1981, FED REG
[2]  
BENGTSSON M, 2005, PATIENT ED COUNS
[3]   Direct effect on validity of response run-in selection in clinical trials [J].
Berger, VW ;
Rezvani, A ;
Makarewicz, VA .
CONTROLLED CLINICAL TRIALS, 2003, 24 (02) :156-166
[4]   VALUE OF A RUN-IN PERIOD IN A DRUG TRIAL DURING PREGNANCY [J].
BLACKWELDER, WC ;
HASTINGS, BK ;
LEE, MLF ;
DELORIA, MA .
CONTROLLED CLINICAL TRIALS, 1990, 11 (03) :187-198
[5]   Nonspecific effects in longitudinal studies: Impact on quality of life measures [J].
Bouchet, C ;
Guillemin, F ;
Briancon, S .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (01) :15-20
[6]   Economic burden of irritable bowel syndrome - Proposed strategies to control expenditures [J].
Camilleri, M ;
Williams, DE .
PHARMACOECONOMICS, 2000, 17 (04) :331-338
[7]   HAWTHORNE EFFECT - IMPLICATIONS FOR PREHOSPITAL RESEARCH [J].
CAMPBELL, JP ;
MAXEY, VA ;
WATSON, WA .
ANNALS OF EMERGENCY MEDICINE, 1995, 26 (05) :590-594
[9]   PARTNER BEHAVIORS THAT SUPPORT QUITTING SMOKING [J].
COHEN, S ;
LICHTENSTEIN, E .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (03) :304-309
[10]  
DALESSION D, 1974, HEADACHE, V11, P109